12:00 AM
 | 
Jun 03, 2013
 |  BC Week In Review  |  Company News  |  Deals

AstraZeneca, Neomed Institute deal

Not-for-profit life sciences research center Neomed and AstraZeneca expanded an existing collaboration to include access to up to 250,000 compounds from AstraZeneca's small molecule compound library to be used to identify candidate compounds for selected targets across a broad...

Read the full 172 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >